Management of premenstrual acne with Cox-2 inhibitors: A placebo controlled study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 70, Issue 6, 2004, Pages 345-349

  Tehrani, Rustom ^a,c   Dharmalingam, Mala ^b  

^a Mallya Hospital   (India)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

^c Citadel   (India)

Author keywords

Premenstrual acne; Prostaglandin; Rofecoxib

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ACNE; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EPIGASTRIC PAIN; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PERIPHERAL EDEMA; PHOTOSENSITIVITY; SIDE EFFECT;

EID: 14844295562     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Stoll S, Shalita AR, Webster GF, Kaplan R, Danesh S, Penstein A. The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001;45:957-60.
2. Lucky AW. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004;140:423-4.
3. Williams M, Cunliffe WJ. Explanation for premenstrual acne. Lancet 1973;2:1055-7.
4. Michaelsson G, Juhlin L, Vahlquist A. Effect of oral zinc and Vitamin A in acne. Arch Dermatol 1977;113:31-6.
5. Tilley SL, Coffman TM, Koller BW. Mixed messages; modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001;108:15-23.
6. Smith KJ, Skeleton H. Arachidonic acid-derived bioactive Lipids: Their role and the role for their inhibitors in dermatology. J Cutan Med Surg 2002;6:241-56.
7. Itesekson A, Lazarov A, Cordoba M, Zeitune M, Abraham D, Seidman DS. Premenstrual Syndrome and associated skin diseases related to hypersensitivity to female sex hormones. J Reprod Med 2004;49:195-9.
8. Fischer DA. Desideratum Dermatologicum-cause and control of premenstrual acne flare. Int J Dermatol 2000;39:334-6.
9. Katz N. Coxibs: Evolving role in pain management. Semin Arthritis Rheum 2002;32:15-24.
10. Mukherjee D. Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-9.
11. Wong RC, Kang S, Heezen JL, Voorhees JJ, Ellis CN. Oral ibuprofen and tetracycline for the treatment of acne. J Am Acad Dermatol 1984;11:1076-81.
12. Hindson C, Lawlor F, Wacks H. Benoxaprofen for nodular acne. Lancet 1982;1:1415.
13. Friedman ES, LaNatra N, Stiller MJ. NSAIDs in dermatologic therapy: Review and preview. J Cutan Med Surg 2002;6:449-59.